EARLY-STAGE MANTLE CELL LYMPHOMA INVOLVING THE STOMACH: SUSTAINED REMISSION AFTER ISOLATED INVOLVED-FIELD RADIOTHERAPY

Autor: Nogueira, RBE, Lijeron, MCM, Abdo, ANR, Velasques, RD, Marchi, LL, Brandão, AAGS, Rego, EM, Rocha, V, Lage, LAPC, Pereira, J

Publikováno v: In Hematology, Transfusion and Cell Therapy October 2023 45 Supplement 4:S355-S355

PRIMARY MEDIASTINAL B-CELL LYMPHOMA IN BRAZIL: INTENSIFIED REGIMEN DOESN'T SEEM TO IMPROVE OUTCOMES WHEN COMPARED TO R-CHOP IN A RESOURCE-CONSTRAINED SCENARIO – A RETROSPECTIVE CHART-REVIEW STUDY

Autor: Velasques, RD, Silva-Júnior, WF, Bellesso, M, Rocha, V, Pereira, J

Publikováno v: In Hematology, Transfusion and Cell Therapy October 2021 43 Supplement 1:S98-S99

Impact of baseline and interim quantitative PET parameters on outcomes of classical Hodgkin Lymphoma.

Autor: Santos FM; Instituto Do Cancer Do Estado de Sao Paulo (ICESP), Faculdade de Medicina, Universidade de Sao Paulo (FMUSP), Sao Paulo-SP, Brazil. fernanda.maria@hc.fm.usp.br., Marin JFG; Nuclear Medicine Medical Investigation Laboratory LIM43, Hospital das Clinicas, FMUSP (HCFMUSP), Sao Paulo-SP, Brazil., Lima MS; Instituto Do Cancer Do Estado de Sao Paulo (ICESP), Faculdade de Medicina, Universidade de Sao Paulo (FMUSP), Sao Paulo-SP, Brazil.; Nuclear Medicine Medical Investigation Laboratory LIM43, Hospital das Clinicas, FMUSP (HCFMUSP), Sao Paulo-SP, Brazil., Silva-Junior WF; Instituto Do Cancer Do Estado de Sao Paulo (ICESP), Faculdade de Medicina, Universidade de Sao Paulo (FMUSP), Sao Paulo-SP, Brazil.; Division of Hematology and Cell Therapy, HCFMUSP, Sao Paulo-SP, Brazil., Alves LBO; Division of Hematology and Cell Therapy, HCFMUSP, Sao Paulo-SP, Brazil., Moreira FR; Division of Hematology and Cell Therapy, HCFMUSP, Sao Paulo-SP, Brazil., Velasques RD; Instituto Do Cancer Do Estado de Sao Paulo (ICESP), Faculdade de Medicina, Universidade de Sao Paulo (FMUSP), Sao Paulo-SP, Brazil.; Division of Hematology and Cell Therapy, HCFMUSP, Sao Paulo-SP, Brazil., Atanazio MJ; Instituto Do Cancer Do Estado de Sao Paulo (ICESP), Faculdade de Medicina, Universidade de Sao Paulo (FMUSP), Sao Paulo-SP, Brazil.; Division of Hematology and Cell Therapy, HCFMUSP, Sao Paulo-SP, Brazil., Maia ACA; Instituto Do Cancer Do Estado de Sao Paulo (ICESP), Faculdade de Medicina, Universidade de Sao Paulo (FMUSP), Sao Paulo-SP, Brazil.; Division of Hematology and Cell Therapy, HCFMUSP, Sao Paulo-SP, Brazil., Buchpiguel CA; Nuclear Medicine Medical Investigation Laboratory LIM43, Hospital das Clinicas, FMUSP (HCFMUSP), Sao Paulo-SP, Brazil., Buccheri V; Instituto Do Cancer Do Estado de Sao Paulo (ICESP), Faculdade de Medicina, Universidade de Sao Paulo (FMUSP), Sao Paulo-SP, Brazil.; Division of Hematology and Cell Therapy, HCFMUSP, Sao Paulo-SP, Brazil.; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Division of Hematology, HCFMUSP, Sao Paulo-SP, Brazil., Rocha V; Instituto Do Cancer Do Estado de Sao Paulo (ICESP), Faculdade de Medicina, Universidade de Sao Paulo (FMUSP), Sao Paulo-SP, Brazil.; Division of Hematology and Cell Therapy, HCFMUSP, Sao Paulo-SP, Brazil.; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Division of Hematology, HCFMUSP, Sao Paulo-SP, Brazil.; Department of Hematology, Churchill Hospital, NHS BT, Oxford University, Oxford, UK.

Publikováno v: Annals of hematology [Ann Hematol] 2024 Jan; Vol. 103 (1), pp. 175-183. Date of Electronic Publication: 2023 Oct 05.

Less Intensive Regimens May Still Be Suitable for the Initial Treatment of Primary Mediastinal B-Cell Lymphoma in Resource-Limited Settings.

Autor: Velasques RD; Instituto do Cancer do Estado de São Paulo, São Paulo, SP, Brazil.; Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clinicas da Faculdade de Medicina da USP, Sao Paulo, SP, Brazil., da Silva WF; Instituto do Cancer do Estado de São Paulo, São Paulo, SP, Brazil.; Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clinicas da Faculdade de Medicina da USP, Sao Paulo, SP, Brazil., Bellesso M; Instituto do Cancer do Estado de São Paulo, São Paulo, SP, Brazil.; Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clinicas da Faculdade de Medicina da USP, Sao Paulo, SP, Brazil., Rocha V; Instituto do Cancer do Estado de São Paulo, São Paulo, SP, Brazil.; Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clinicas da Faculdade de Medicina da USP, Sao Paulo, SP, Brazil.; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hospital das Clinicas da Faculdade de Medicina da USP, Sao Paulo, SP, Brazil.; Churchill Hospital, Oxford University, Oxford, UK., Pereira J; Instituto do Cancer do Estado de São Paulo, São Paulo, SP, Brazil.; Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clinicas da Faculdade de Medicina da USP, Sao Paulo, SP, Brazil.; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hospital das Clinicas da Faculdade de Medicina da USP, Sao Paulo, SP, Brazil.

Publikováno v: Journal of oncology [J Oncol] 2022 Jun 06; Vol. 2022, pp. 2099456. Date of Electronic Publication: 2022 Jun 06 (Print Publication: 2022).

Reassessment of risk factors and long-term results of autologous stem cell transplantation in relapsed and refractory classical Hodgkin lymphoma.

Autor: Fatobene G, Linardi CDCG, Moreira F; Discipline of Hematology, Transfusion and Cell Therapy, Hospital das Clinicas, Faculty of Medicine, University of São Paulo, São Paulo, Brazil., Targueta GMF, Santos FM, Velasques RD, Rocha V, Buccheri V

Publikováno v: Hematological oncology [Hematol Oncol] 2019 Aug; Vol. 37 (3), pp. 310-313. Date of Electronic Publication: 2019 May 30.